In 1977, two Swiss researchers did something beautifully weird: they took blood from a sleeping rabbit, filtered out the small molecules, and injected them into an awake rabbit. The awake rabbit fell into deep delta-wave sleep. Something in the blood was carrying a sleep signal.
They isolated it, sequenced it, and named it delta sleep-inducing peptide — DSIP. Nine amino acids. Crosses the blood-brain barrier. Active at nanomolar concentrations. And nearly 50 years later, it’s still one of the most intriguing peptides in sleep and stress research.
This compound is supplied exclusively for in vitro and preclinical research. It is not intended for human consumption, therapeutic application, or diagnostic use.
The Discovery: Cross-Circulation and a Sleeping Rabbit
Schoenenberger and Monnier’s experiment was elegant in its simplicity. Using a cross-circulation model, they dialyzed blood from sleeping rabbits and collected the low-molecular-weight fraction. When infused into awake recipients, it reliably induced delta-wave sleep — the deepest stage of non-REM sleep, characterized by the slow, high-amplitude brain waves associated with physical restoration and memory consolidation.
The active peptide turned out to be Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu — just nine residues. It was among the first endogenous peptides ever linked specifically to sleep regulation.
More Than a Sleep Peptide
Here’s what makes DSIP fascinating: despite the name, sleep modulation is just one piece of its research profile. Published studies have explored roles in:
- Stress response and adaptation — DSIP has been studied as a “stress-limiting” peptide, with research showing modulation of the hypothalamic-pituitary-adrenal (HPA) axis and altered cortisol/corticosterone responses under stress conditions
- Neuroendocrine regulation — effects on LH, GH, and other pituitary hormone release patterns
- Oxidative stress protection — antioxidant properties observed in both cell culture and animal models
- Pain modulation — analgesic effects documented in several preclinical models
- Circadian rhythm normalization — rather than simply inducing sleep, DSIP appears to help normalize disrupted sleep-wake cycles
The Sleep Research
The original sleep findings have been both replicated and complicated by subsequent research. DSIP doesn’t work like a sedative — it doesn’t knock you out. Instead, studies suggest it promotes physiological sleep architecture, particularly enhancing delta-wave (slow-wave) sleep without suppressing REM sleep. That’s an important distinction: most sleep-promoting drugs either reduce sleep quality or disrupt normal sleep staging. DSIP appears to enhance the most restorative phase.
Graf and Kastin (1984) provided evidence that DSIP crosses the blood-brain barrier through a saturable transport system — not just passive diffusion — suggesting the brain actively imports it. This was unusual for a peptide and supported the idea that DSIP has a specific physiological role in the CNS.
The Stress-Limiting Research
Russian research groups have been particularly active in studying DSIP’s stress-modulatory effects. Sudakov et al. published a series of studies showing that DSIP administration prior to stress exposure altered the hormonal and behavioral stress response in animal models — reducing cortisol/corticosterone elevation, preventing stress-induced hypertension, and normalizing disrupted feeding behavior.
The proposed mechanism: DSIP appears to modulate HPA axis reactivity rather than simply suppressing it. Animals treated with DSIP still mounted a stress response, but it was better regulated — the system turned on when needed and turned off when the stressor passed. This “adaptive” rather than “suppressive” profile is what makes the stress research interesting.
Antioxidant Properties
Bondarenko (2004) and colleagues demonstrated that DSIP exhibited direct and indirect antioxidant activity. In cell culture models, DSIP reduced markers of oxidative damage and enhanced antioxidant enzyme activity. In animal models of oxidative stress, DSIP treatment was associated with improved tissue glutathione levels and reduced lipid peroxidation — markers of cellular oxidative protection.
The Honest Complexities
DSIP research isn’t without its complications:
- No identified receptor: Despite decades of study, the specific receptor through which DSIP exerts its effects hasn’t been definitively identified. This is unusual for a bioactive peptide and makes mechanistic research challenging.
- Stability questions: DSIP is relatively susceptible to enzymatic degradation in plasma, which has led to research on modified analogs with improved half-lives.
- Variable sleep results: While many studies confirm sleep-promoting effects, some researchers have reported inconsistent or dose-dependent results, suggesting the relationship between DSIP and sleep is more complex than the original “sleep-inducing” name implies.
- Concentration of research: A significant portion of DSIP research comes from Russian and Eastern European groups, with less independent replication from Western labs than some other research peptides.
These aren’t deal-breakers — they’re the normal scientific process of a research area that’s still developing. The multi-system effects of DSIP (sleep + stress + antioxidant + neuroendocrine) suggest it may be acting on fundamental regulatory mechanisms rather than a single isolated pathway.
Product Specifications
- Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Molecular Weight: 848.82 g/mol
- CAS Number: 62568-57-4
- Physical Form: Sterile lyophilized white powder
- Purity: ≥99% (verified by HPLC)
- Solubility: Freely soluble in bacteriostatic water
Key References
- Schoenenberger GA, Monnier M. Characterization of a delta-EEG sleep-inducing peptide. Proc Natl Acad Sci. 1977;74(3):1282-1286.
- Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. 1984;8(1):83-93.
- Sudakov KV, et al. Delta sleep-inducing peptide as a factor of resistance to emotional stress. Ann NY Acad Sci. 1995;771:240-251.
- Bondarenko TI. Molecular mechanisms of biological activity of DSIP. Neurochemistry. 2004;21(1):1-10.
Browse DSIP 5mg with verified COA from Janoshik Analytical. For related sleep and neuropeptide research, explore Selank and Semax.